CN102626477B - 治疗陈年跌打损伤外用中草药组合物 - Google Patents
治疗陈年跌打损伤外用中草药组合物 Download PDFInfo
- Publication number
- CN102626477B CN102626477B CN 201210120824 CN201210120824A CN102626477B CN 102626477 B CN102626477 B CN 102626477B CN 201210120824 CN201210120824 CN 201210120824 CN 201210120824 A CN201210120824 A CN 201210120824A CN 102626477 B CN102626477 B CN 102626477B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- traumatic injury
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000014674 injury Diseases 0.000 title claims abstract description 14
- 230000008736 traumatic injury Effects 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 title abstract description 14
- 241000411851 herbal medicine Species 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 10
- 235000013705 Vitis romanetii Nutrition 0.000 claims description 4
- 241000707167 Vitis romanetii Species 0.000 claims description 4
- 239000008361 herbal raw material Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 239000002994 raw material Substances 0.000 abstract description 2
- 240000005748 Achyranthes aspera Species 0.000 abstract 1
- 235000005517 Achyranthes aspera Nutrition 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000219106 Bryonia Species 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 241000208829 Sambucus Species 0.000 abstract 1
- 235000018735 Sambucus canadensis Nutrition 0.000 abstract 1
- 235000007123 blue elder Nutrition 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 235000007124 elderberry Nutrition 0.000 abstract 1
- 235000008995 european elder Nutrition 0.000 abstract 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 241000717739 Boswellia sacra Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 241000903946 Clematidis Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000004863 Frankincense Substances 0.000 description 3
- 241001057584 Myrrha Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000001617 migratory effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000701413 Aconitum kusnezoffii Species 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241001271907 Baphia racemosa Species 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- SCULJPGYOQQXTK-OLRINKBESA-N Cinobufagin Chemical compound C=1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C)CC[C@H](O)C[C@H]5CC[C@H]4[C@@]43O[C@@H]4[C@@H]2OC(=O)C)C=CC(=O)OC=1 SCULJPGYOQQXTK-OLRINKBESA-N 0.000 description 1
- SCULJPGYOQQXTK-UHFFFAOYSA-N Cinobufagin Natural products CC(=O)OC1C2OC22C3CCC4CC(O)CCC4(C)C3CCC2(C)C1C=1C=CC(=O)OC=1 SCULJPGYOQQXTK-UHFFFAOYSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241001489978 Eupolyphaga Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010021750 Infantile Spasms Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 241000322338 Loeseliastrum Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241001180876 Saposhnikovia Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- 206010049514 Traumatic fracture Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- YGJXLMNSTLJAMX-GCUFGPJWSA-N aconitane Chemical compound C([C@@H]1[C@H]2C[C@H]3C4NC1)CC[C@]42[C@@H]1C[C@H]2C[C@@H]1[C@@H]3CC2 YGJXLMNSTLJAMX-GCUFGPJWSA-N 0.000 description 1
- 229930009543 aconitane Natural products 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229960000796 barbital sodium Drugs 0.000 description 1
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 208000013257 developmental and epileptic encephalopathy Diseases 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- -1 flavanone glycosides Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- XMFOQHDPRMAJNU-UHFFFAOYSA-N lead(ii,iv) oxide Chemical compound O1[Pb]O[Pb]11O[Pb]O1 XMFOQHDPRMAJNU-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- BCZFSDNVXODRAJ-JTTNIQEDSA-N lycopodine Chemical compound C1CCN2CCC[C@@H]3[C@H]4C[C@@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-JTTNIQEDSA-N 0.000 description 1
- BCZFSDNVXODRAJ-ZHMBSYLPSA-N lycopodine Natural products C1CCN2CCC[C@@H]3[C@H]4C[C@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-ZHMBSYLPSA-N 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 239000003169 respiratory stimulant agent Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229930002600 steroidal saponin Natural products 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Abstract
一种治疗陈年跌打损伤外用中草药组合物，各中草药原料按重量配比为：穿山龙30、川乌20、自然铜20、鸡血藤20、桑枝20、接骨30、草乌15、野葡萄15、土牛膝20、天南星15、伸筋草30、青木香25、骨碎补30、络石藤20、松节30、红花20。它治疗费用低，治疗效果好。
Description
技术领域
本发明涉及一种中药组合物，尤其是指一种治疗陈年跌打损伤外用中草药组合物。
背景技术
中医中药在治疗外伤性骨折、扭伤肿痛病症方面有其独特的疗效。现有技术公开的中草药配方各有其药效。如中国专利曾公开了“一种治疗跌打损伤外敷中药制剂”(中国，公开号CN1226432A，公布日1999年8月25日)，其组成有当归、杜仲、川芎、乳香等十五种中药材制成，将以上十五种中药研成细粉，加入凡士林调制成膏状粘在敷料的白布上。中国专利曾公开了“一种治疗跌打损伤外用药”(中国，公开号CN1391939A，公布日2003年1月22日)，各成分及配比按重量份如下：a.当归1～3份、乳香3～9份、没药5～15份、然同3～9份、红花1～3份、防风3～9份、血竭3～9份、冰片0.5～1.5份；b.松香与上述八味中药总量比为1∶0.05～0.2；c.松香与香油比为1∶0.15。中国专利曾公开了一种“用于跌打损伤恢复期的外用膏药”(中国，公开号CN1426809A，公布日2003年7月2日)，它是由以下重量比的中药原料制成：楤木根皮400～600、夏枯草80～120、金沸草8～12、千里光15～25、乳香25～35、没药25～35、红花180～220、植物油2500～3500、四氧化三铅900～1200、水芹菜60～100。中国专利曾公开了“一种治疗跌打损伤的外用药物及其制备方法”(中国，公开号CN1439417A，公布日2003年9月3日)，其主要由三七、川乌、草乌、川芎、乳香、没药、威灵仙、丁香、栀子、大黄、黄柏、海风藤、三棱、续断、土鳖虫、当归等四十四味中药按一定重量配比制备而成。中国专利曾公开了“一种生肌接骨外用中草药组合物”(中国，公布号CN102218131A，公布日2011年10月19日)，由五爪金龙1.5-2.2，大通草0.5-1.0，紫木通0.5-1.0，仙人掌3-4，生姜0.1-0.3，45-56度酒2-2.5配制而成。
发明内容
本发明的目的在于提供一种治疗陈年跌打损伤外用中草药组合物，治疗费用低，治疗效果好。
为达到上述目的，本发明采取如下的技术方案：一种治疗陈年跌打损伤外用中草药组合物，各中草药原料按重量配比为：穿山龙30、川乌20、自然铜20、鸡血藤20、桑枝20、接骨30、草乌15、野葡萄15、土牛膝20、天南星15、伸筋草30、青木香25、骨碎补30、络石藤20、松节30、红花20。
本发明是在祖传方剂的基础上，根据临床实践，对患者的用药跟踪观察，不断调整配方，形成上述成方。它治疗费用低，效果好。各中草药易得，用量少，价格低，外敷方便，便于携带保存。
具体实施方式
一种治疗陈年跌打损伤外用中草药组合物，各中草药原料配比为：穿山龙30g、川乌20g、自然铜20g、鸡血藤20g、桑枝20g、接骨木30g、草乌15g、野葡萄15g、土牛膝20g、天南星15g、伸筋草30g、青木香25g、骨碎补30g、络石藤20g、松节30g、红花20g。
各中草药经科学配伍，制成药饼药膏，外敷于患处，充分发挥它们的药效。它们的药理作用简述如下。
穿山龙：有明显的止咳、去痰、平喘作用，对组胺或乙酞胆碱喷雾引起的支气管痉挛均有预防作用，此作用有效成分在极性最强的部分及甾体皂苷，能够降低兔血胆固醇及血压，延缓心率、增大心肌收缩振幅、增加尿量、改善冠豚脉循环，可治疗轻度动脉粥样硬化。
川乌：川乌头有抗炎、镇痛、镇静、局部麻醉等作用，川乌头生品及炮制品水煎剂有强心作用，乌头多糖有降血糖作用，川乌有较强毒性，中毒时，呼吸兴奋、流涎、运动麻痹、手足痉挛，乌头注射液对胃癌细胞有抑制作用。
自然铜：用于散瘀，接骨止痛、跌打损伤、肿痛、筋骨折伤，对家兔人工骨折有促进骨痂的生长和成熟、加速骨折愈合的作用，能促范骨髓本身及其周围血液中网状细胞和血红蛋白的增生等作用。
鸡血藤：鸡血藤有扩强血管作用，如水提醇沉制直接注入动物犬股脉，显示动脉内血流量增加，阻力减少、水煎醇沉制剂对大鼠实验性血小板豚集有明疗效，有促进小鼠肾脏及子宫总磷代射的作用，对家兔实验性贫血有补血作用，煎剂对金黄色葡萄球菌有抑制作用。
桑枝：桑枝皮能使尿中排出氯化物增加而具有利尿作用，有较强的抗炎活性，可提高人体淋巴细胞转化率、具有增强免疫功能的作用。
草乌：草乌头注射液有明显的镇痛作用，所含生物碱是其主要镇痛成分，煎制有抗炎作用，可促进蛋清所致大鼠足跖水肿消退，北乌头总碱能增强肾上腺素对心肌的作用，对抗氯化钙所致T波倒置，对抗垂体后叶素致市期的ST段上升或迷继之发生的ST段下降。
野葡萄：用于清热解毒，疗疮痈肿、目赤肿痛，有明显降压的作用，有抗病毒抗菌作用，对金黄色葡萄球菌、白喉杆菌及痢疾杆菌均有抑制作用。
土牛膝：牛膝醇提取液具有增强衰竭心脏功能，降低血压和兴奋呼吸作用，能降低全血黏度、血细胞比容细胞聚集指数、延长凝血醄原时间和血浆复钙时间，牛膝多糖有免疫调节作用和抗肿瘤作用，并有较强的蛋白成促进作用，牛膝总苷对受孕和朱孕子宫有兴奋作用，牛膝总皂苷有明显的抗生育作用，此外：牛膝有抗炎消肿和镇痛功效，还具抗衰老作用。
天南星：天南星煎剂给兔、大鼠腺腔注射出沉活动减少安静，反应迟钝、明显延长小鼠巴比妥钠的睡眠时间，试验研究表明中枢镇静作用，小鼠热板应有明显镇痛作用，另外，天南星水提物具有抗肿瘤作用和明显祛痰作用。
伸筋草：伸筋草水浸剂有解热作用，醇提取液有镇痛作用，能显著延长戊巴比妥钠催眼小鼠的睡眼时间，石松碱对离体大鼠、豚鼠小肠及子宫有兴奋作用，有利尿作用，能增加尿酚排泄，还能解除小儿痉挛性尿潴留及便秘等。
青木香：青木香用于肝胃气滞所致的胸胁刺痛，脘胀痛，疝气痛，湿热下痢，内伤暑湿而致的泻痢腹痛，还治筋中之毒，也有镇痛消炎作用。
骨碎补：骨碎补炮制品水煎剂对于实验性骨关节炎有治疗功效，能推迟退行性病变，骨碎补对链霉素所致的毒副反应有明显解毒作用，骨碎补双氢黄酮苷具有保肝解毒作用，多糖酚盐有降血脂功效，另外，尚有抗血聚集，抗菌、固乐作用。
络石藤：络石藤对金黄色葡萄球菌、福氏痢疾杆菌及伤寒杆菌有抑制作用，所含的牛蒡苷可引起的血管扩张血压降低，可使冷血及温血动物产生惊瘚，大剂量可引起呼吸衰竭，并使小鼠皮肤发红腹泻对离体兔肠及子宫有抑制作用
松节：松节用于寒湿风痹，历关节风痛，跌打损伤，用于镇痛、抗炎、抗肿瘤作用，监床方可用于治疗历节风、大骨节病丿脚气转筋、疼痛挛急等作用。
红花：红花能增加冠脉血流、抗心肌缺血、抑制血小板聚集和增强纤维蛋白溶解、改善微循环，红花油降低血清总胆固醇和三酰甘油，红花煎剂对已字和末孕子宫有兴奋作用，甚至引起痉挛，红花能润泽肌肤，使角质软化，红花黄素有明显镇静，镇痛效果。
威灵仙：威灵仙煎剂能提高痛感，具有一定的镇痛作用，煎剂和醇提取物能促进大鼠胆汁分泌，对离体兔肠平滑肌有对抗菌胺的兴奋作用，对金黄色葡萄菌，志贺氏痢疾杆菌有抑制作用，浸剂和煎剂小鼠，大鼠和豚鼠均有显著的利尿作用。
该药治疗患者162例，陈年患者23天至35天治愈，较轻的患者12天至21天治愈，坚持住的患者治愈可达100％。
Claims (1)
1.一种治疗陈年跌打损伤外用中草药组合物，其特征在于各中草药原料按重量配比为：穿山龙30、川乌20、自然铜20、鸡血藤20、桑枝20、接骨30、草乌15、野葡萄15、土牛膝20、天南星15、伸筋草30、青木香25、骨碎补30、络石藤20、松节30、红花20。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210120824 CN102626477B (zh) | 2012-04-10 | 2012-04-10 | 治疗陈年跌打损伤外用中草药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210120824 CN102626477B (zh) | 2012-04-10 | 2012-04-10 | 治疗陈年跌打损伤外用中草药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102626477A CN102626477A (zh) | 2012-08-08 |
| CN102626477B true CN102626477B (zh) | 2013-11-06 |
Family
ID=46584985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210120824 Expired - Fee Related CN102626477B (zh) | 2012-04-10 | 2012-04-10 | 治疗陈年跌打损伤外用中草药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102626477B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083489B (zh) * | 2013-01-24 | 2014-09-17 | 王林祥 | 治腰椎病、颈椎病、骨质增生早期、陈年旧伤的中药酒剂 |
| CN105434694A (zh) * | 2015-12-19 | 2016-03-30 | 陈玉勇 | 一种治疗跌打损伤的药物及其制备方法 |
| CN107998246B (zh) * | 2018-01-18 | 2021-02-12 | 上海市普陀区人民医院 | 一种治疗跌打损伤所致慢性软组织损伤或骨关节痛的中药组合物及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1104249C (zh) * | 1997-11-18 | 2003-04-02 | 刘道成 | 七合接骨膏附稳骨擦剂 |
-
2012
- 2012-04-10 CN CN 201210120824 patent/CN102626477B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102626477A (zh) | 2012-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104107299A (zh) | 一种治疗痛经的中药混合物 | |
| CN103893727A (zh) | 一种止痛活血舒筋贴膏及其制备方法 | |
| CN103751734B (zh) | 活血止痛巴布膏及其制备方法 | |
| CN103405582B (zh) | 改善类风湿关节炎关节肿痛的中药组合物 | |
| CN102626477B (zh) | 治疗陈年跌打损伤外用中草药组合物 | |
| CN103611133A (zh) | 活血止痛凝胶及其制备方法 | |
| CN102626443B (zh) | 治疗痛风中草药组合物 | |
| CN102895610A (zh) | 一种治疗水肿的药物 | |
| CN105214032A (zh) | 治疗消化性溃疡的固体分散片剂 | |
| CN101869671A (zh) | 腰腿肩颈膏 | |
| CN104689132A (zh) | 一种治疗银屑病的中药组合物 | |
| CN1272027C (zh) | 治疗泌尿系统结石、感染及胆囊结石、胆囊炎的金钱草制剂及其生产方法 | |
| CN113244356A (zh) | 用于治疗银屑病的中药组合物 | |
| CN105250946A (zh) | 治疗消化性溃疡的固体分散体 | |
| CN105214037A (zh) | 治疗消化性溃疡的固体分散胶囊剂 | |
| CN105616536A (zh) | 一种治疗白癜风的中药擦剂 | |
| CN1250249C (zh) | 一种治疗妇科炎症的中药外用洗剂 | |
| CN109771567A (zh) | 一种中草药扶正化瘀排毒化肿瘤的配方 | |
| CN102626479B (zh) | 治疗陈年风湿骨病外用中草药组合物 | |
| CN110251564B (zh) | 一种治疗痛风关节炎的外用药及其制备方法 | |
| CN108324829A (zh) | 一种含人参的抗休克合剂及其制备方法 | |
| CN112402566B (zh) | 一种中药组合物在制备治疗膝关节滑膜炎的药物中的用途 | |
| CN112402565B (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
| CN106511688A (zh) | 一种用于剖宫产瘢痕部位妊娠及胎盘植入的中药组合物、制备方法及服用方法 | |
| CN1069038C (zh) | 跌打万应膏及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131106 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |